|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$314,516
|
$314,516
|
Barchi, Joseph
|
CCR (NCI)
|
|
A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC
|
ZIA BC 011786
|
$30,836
|
$30,836
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$30,836
|
$30,836
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$107,655
|
Barr, Frederic
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,857,052
|
$742,855
|
Custer, Mary
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
$37,654
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$387,112
|
$270,978
|
Buck, Christopher
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$331,774
|
$331,774
|
Apolo, Andrea
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$3,493,116
|
$349,312
|
Restifo, Nicholas
|
CCR (NCI)
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$303,808
|
$30,381
|
Lim, Langston
|
CCR (NCI)
|
|
Characterization of Biological Nanoparticle Subsets
|
ZIA BC 011502
|
$344,939
|
$17,247
|
Jones, Jennifer
|
CCR (NCI)
|
|
Clinical Fellowship Training Program
|
ZIE BC 011023
|
$553,378
|
$276,689
|
Pinto, Peter
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$660,228
|
$429,148
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$440,152
|
$330,114
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Comparison of molecular factors to drug activities
|
ZIC BC 011509
|
$59,036
|
$5,904
|
Reinhold, William
|
CCR (NCI)
|
|
Consequences of chronic Interferon-gamma expression on the host
|
ZIA BC 009283
|
$1,117,083
|
$55,854
|
Young, Howard
|
CCR (NCI)
|
|
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
|
ZIA BC 011488
|
$1,073,783
|
$214,757
|
Meier, Jordan
|
CCR (NCI)
|
|
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
|
ZID BC 011792
|
$244,173
|
$24,417
|
Pack, Svetlana
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$330,596
|
$99,179
|
Beutler, John
|
CCR (NCI)
|
|
Dysregulation of Antigen Presenting Cell Function in Cancer
|
ZIA BC 011687
|
$248,758
|
$24,876
|
Roche, Paul
|
CCR (NCI)
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,978,942
|
$197,894
|
Gress, Ronald
|
CCR (NCI)
|
|
Experimental Pathology Laboratory (EPL)
|
ZIC BC 011638
|
$1,213,497
|
$121,350
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410 08285
|
$76,748
|
$7,675
|
Savage, Sharon
|
DCEG (NCI)
|
|
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
|
ZIA BC 011337
|
$177,955
|
$53,386
|
Yang, James
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$584,807
|
$35,088
|
Gottesman, Michael
|
CCR (NCI)
|
|
Genetics of Complex Diseases and Health Disparities
|
ZIA BC 010022
|
$588,017
|
$588,017
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Genomics and Bioinformatics Group web site development and maintenance
|
ZIC BC 011475
|
$265,660
|
$53,132
|
Reinhold, William
|
CCR (NCI)
|
|
Growth-Differentiation Factors in Organogenesis
|
ZIA BC 005093
|
$634,620
|
$571,158
|
Perantoni, Alan
|
CCR (NCI)
|
|
High Throughput Screening of Agents in Bladder Cancer Cell Lines
|
ZIC BC 011531
|
$61,672
|
$61,672
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,365,668
|
$68,283
|
Chinquee, Joseph
|
CCR (NCI)
|
|
HSP90 Chaperone Proteins & Chaperone Interactors in Cellular Signal Transduction
|
ZIA SC 010074
|
$620,818
|
$248,327
|
Neckers, Leonard
|
CCR (NCI)
|
|
Hypoxia and Tyrosine Kinase Signaling Integration in Urologic Cancers
|
ZIA BC 011095
|
$213,470
|
$213,470
|
Bottaro, Donald
|
CCR (NCI)
|
|
Identification of Genetic Factors Associated with Infectious Diseases
|
ZIA BC 010297
|
$252,007
|
$100,803
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$526,810
|
$26,341
|
Khan, Javed
|
CCR (NCI)
|
|
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
|
ZIB BC 010906
|
$1,949,215
|
$779,686
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Investigation of Epigenetic Modifiers in Bladder Cancer
|
ZIA BC 011593
|
$154,179
|
$154,179
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Mechanisms of Immune-mediated Tumor Cell Destruction
|
ZIA BC 010012
|
$104,698
|
$41,879
|
Sayers, Thomas
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$804,110
|
$40,206
|
Gottesman, Michael
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$3,561,926
|
$534,289
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Metabolic characterization of FH- and SDH-deficient RCC cell lines
|
ZIA BC 011701
|
$126,682
|
$126,682
|
Moscow, Jeffrey
|
CCR (NCI)
|
|
microRNA Profiling in the Spectrum of Kidney Tumors
|
ZIA BC 011405
|
$122,272
|
$122,272
|
Merino, Maria
|
CCR (NCI)
|
|
Molecular biology of human polyomaviruses
|
ZIA BC 011090
|
$387,112
|
$193,556
|
Buck, Christopher
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$865,192
|
$346,077
|
Hou, Steven
|
CCR (NCI)
|
|
Molecular Mechanisms of Cancer Development
|
ZIC BC 011842
|
$162,782
|
$16,278
|
Pack, Svetlana
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZIC BC 011075
|
$61,417
|
$30,709
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$2,313,288
|
$462,657
|
Edelman, Daniel
|
CCR (NCI)
|
|
Molecular Targeted Photoimmunotherapy for Bladder Cancer
|
ZIA BC 011458
|
$185,015
|
$185,015
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
|
ZIA BC 011043
|
$880,303
|
$871,500
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$880,303
|
$660,227
|
Linehan, W. Marston
|
CCR (NCI)
|
|
New Virus Identification
|
ZIA CP010150 10817
|
$1,179
|
$590
|
Engels, Eric
|
DCEG (NCI)
|
Total relevant funding to Urinary System for this search: $17,394,762
|